Published in Ann Surg on August 01, 2015
Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg (2012) 7.26
Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14
Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg (2011) 2.02
CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol (2012) 1.76
Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg (2009) 1.54
Anaplastic pancreatic cancer: Presentation, surgical management, and outcome. Surgery (2010) 1.49
Stimulation of Central α2 Receptors Attenuates Experimental Necrotizing Pancreatitis. Pancreas (2016) 1.38
Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol (2013) 1.34
Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol (2012) 1.21
Pathology of the large intestine in patients with vascular type Ehlers-Danlos syndrome. Virchows Arch (2007) 1.12
Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg (2010) 1.08
Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg (2015) 1.02
Decrease in clinically relevant pancreatic fistula by coverage of the pancreatic remnant after distal pancreatectomy. Surgery (2012) 0.99
Radiologic versus endoscopic evaluation of the conduit after esophageal resection: a prospective, blinded, intraindividually controlled diagnostic study. Surg Endosc (2014) 0.99
Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer. Surgery (2012) 0.96
Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease? Am J Surg (2011) 0.95
Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg (2015) 0.92
Survival data justifies resection for pancreatic metastases. Ann Surg Oncol (2009) 0.91
Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg (2014) 0.91
Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis. Crit Care (2008) 0.90
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery (2012) 0.90
Modern phase-specific management of acute pancreatitis. Dig Dis (2003) 0.86
LigaSure for pancreatic sealing during distal pancreatectomy. World J Surg (2010) 0.86
A novel animal model of severe pancreatitis in mice and its differences to the rat. Surgery (2008) 0.85
Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma. J Immunother (2008) 0.85
No Need for Routine Drainage After Pancreatic Head Resection: The Dual-Center, Randomized, Controlled PANDRA Trial (ISRCTN04937707). Ann Surg (2016) 0.85
Acute alcohol-induced pancreatic injury is similar with intravenous and intragastric routes of alcohol administration. Pancreas (2014) 0.84
Reactive hypertrophy of an accessory spleen mimicking tumour recurrence of metastatic renal cell carcinoma. Asian J Surg (2011) 0.83
Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitis. Pancreatology (2009) 0.83
Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer. BMC Cancer (2012) 0.82
Growth inhibition of pancreatic cancer by experimental treatment with 4-phenylbutyrate is associated with increased expression of Connexin 43. Oncol Res (2012) 0.82
Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial. Trials (2014) 0.82
Effects of gadolinium chloride and glycine on hepatic and pancreatic tissue damage in alcoholic pancreatitis. Pancreas (2010) 0.81
Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention. Am J Physiol Gastrointest Liver Physiol (2006) 0.81
Inosine reduces microcirculatory disturbance and inflammatory organ damage in experimental acute pancreatitis in rats. Am J Surg (2006) 0.80
Pharmacological cholinergic stimulation as a therapeutic tool in experimental necrotizing pancreatitis. Pancreas (2014) 0.80
Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery (2012) 0.80
Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells. Pediatr Nephrol (2012) 0.79
Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas (2016) 0.79
Pancreatic intraductal papillary mucinous neoplasm--where is the challenge? Dig Dis (2014) 0.79
Capsaicin reduces tissue damage in experimental acute pancreatitis. Pancreas (2009) 0.78
Alcohol pretreatment increases hepatic and pulmonary injury in experimental pancreatitis. Pancreatology (2009) 0.78
Multidrug strategies are effective in the treatment of severe experimental pancreatitis. Surgery (2011) 0.78
Enterokinase induces severe necrosis and rapid mortality in cerulein pancreatitis: characterization of a novel noninvasive rat model of necro-hemorrhagic pancreatitis. Surgery (2007) 0.78
Expression and function of matrix Gla protein in human peritoneal mesothelial cells. Nephrol Dial Transplant (2010) 0.78
Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis. Langenbecks Arch Surg (2015) 0.77
Fundus rotation gastroplasty vs. Kirschner-Akiyama gastric tube in esophageal resection: comparison of perioperative and long-term results. World J Surg (2008) 0.77
Teres Ligament Patch Reduces Relevant Morbidity After Distal Pancreatectomy (the DISCOVER Randomized Controlled Trial). Ann Surg (2016) 0.77
Differential diagnosis of non-epithelial tumors of the pancreas: malignant non-epithelial pancreatic tumor with focal pigmentation. Virchows Arch (2004) 0.77
Correlation of Histological Vessel Characteristics and Diffusion-Weighted Imaging Intravoxel Incoherent Motion-Derived Parameters in Pancreatic Ductal Adenocarcinomas and Pancreatic Neuroendocrine Tumors. Invest Radiol (2015) 0.76
Pancreatic Cancer Surgery: The New R-status Counts. Ann Surg (2016) 0.76
Nutritional Risk in Major Abdominal Surgery: Protocol of a Prospective Observational Trial to Evaluate the Prognostic Value of Different Nutritional Scores in Pancreatic Surgery. JMIR Res Protoc (2015) 0.75
Multiple von Meyenburg complexes mimicking diffuse liver metastases from esophageal squamous cell carcinoma. World J Gastroenterol (2006) 0.75
Expanding the indications of pancreas transplantation alone. Pancreas (2014) 0.75
Renal tumors and second primary pancreatic tumors: a relationship with clinical impact? Patient Saf Surg (2012) 0.75
Extended Pancreatectomy: Does It Have a Role in the Contemporary Management of Pancreatic Adenocarcinoma? Dig Surg (2017) 0.75
Reply to Comment on "Teres Ligament Patch Reduces Relevant Morbidity After Distal Pancreatectomy (the DISCOVER Randomized Controlled Trial)". Ann Surg (2017) 0.75
Expect the unexpected. Int J Surg Pathol (2010) 0.75
Clinical Impact of Structured Follow-up After Pancreatic Surgery. Pancreas (2016) 0.75
Mesocaval stenting for therapy of portal hypertension after orthotopic liver transplantation. Transpl Int (2006) 0.75
Clinical impact of perioperative myocardial infarction after pancreatic surgery. J Gastrointest Surg (2014) 0.75
Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer. Pancreas (2017) 0.75
Superselective embolization for the management of postpancreatectomy hemorrhage: a single-center experience in 25 patients. J Vasc Interv Radiol (2012) 0.75